Results 151 to 160 of about 8,334 (239)

From discovery to the clinic: structural insights, engineering options, clinical, and 'next wave' applications of camelid-derived single-domain antibodies. [PDF]

MAbs
Evers A, Guarnera E, Pekar L, Zielonka S.   +3 more
europepmc   +1 more source

A Unified Dataset for Antibody and Nanobody Design Including Sequence, Structure, and Binding Affinity Data. [PDF]

Sci Data
Wu Y, Liu X, Hrovatin K, Wu D, Linker S, Winkel M, Tan F.   +6 more
europepmc   +1 more source

Effectiveness of coproscopic concentration techniques

Helminthologia, 2014
Taglioretti V., Sardella N., Fugassa M.
doaj   +1 more source

From Phage Display to Yeast Secretion: Developing Fc-Fused Nanobodies Against Influenza Virus. [PDF]

Cells
Wang M, Li S, Li Y, Xia X, Zhang Y, Cao N, Li Y, Liu Y, Zhang S, Zhang L, Huang J.   +10 more
europepmc   +1 more source

Unique antibodies across the animal kingdom (birds, camelids, and sharks): therapeutic potential against human respiratory viral infections. [PDF]

Front Immunol
Basabrain AA, Alandijany TA.
europepmc   +1 more source

Peripheral Nerve Infiltration by CAR T-cells in a Case of Mononeuritis Multiplex after Ciltacabtagene Autoleucel. [PDF]

Blood Cell Ther
Hosoya H, Song KW, Dyson K, Dufort G, Sahaf B, Rosenberg A, Sidana S, Miklos D, Vogel H, Fernandez-Pol S, Muppidi S, Scott B, Mikkilineni L.   +12 more
europepmc   +1 more source

Camelids Are Not Ruminants

, 2008
openaire   +1 more source

Species-Dependent Structural Variations in Single-Domain Antibodies. [PDF]

Antibodies (Basel)
Baselga M, Sánchez-Prieto J, Medina Pérez VM, Schuhmacher AJ.   +3 more
europepmc   +1 more source

Genomic diversity and host-specificity in <i>Corynebacterium pseudotuberculosis</i> using comparative population genomics. [PDF]

Front Microbiol
Profeta R, Schlesener CL, Shaw CA, Busch RC, Heller MC, Spier S, Wu J, Welch S, Viana MVC, Barroso FAL, Brenig B, Azevedo V, Weimer BC.   +12 more
europepmc   +1 more source

Structural and functional evolution of IL-1 targeting: From systemic neutralization to bioengineered nanotherapies. [PDF]

Mater Today Bio
Yang L, Chen G, Lyu Z.
europepmc   +1 more source